skip to content »


Houston, Texas

The Alkek Building at Baylor College of Medicine
Section of Pulmonary, Critical Care, and Sleep Medicine
not shown on screen

Marcia F. Katz, M.D.

Marcia Katz, M.D.Brown Foundation Professor of Adult Cystic Fibrosis
Director, Adult Cystic Fibrosis Center
Associate Professor of Medicine

Baylor College of Medicine
One Baylor Plaza - BCM621
Houston, Texas 77030
Phone: 713-798-2400
Fax: 713-798-2688


  • M.D., Boston University School of Medicine, Boston, Mass.
  • Residency, Internal Medicine, Boston City Hospital, Boston, Mass.
  • Fellowship, Pulmonary and Critical Care, Pulmonary Center, Boston University School of Medicine, Boston, Mass.

Research Interests

Dr. Katz is the co-principle investigator of the BCM Therapeutics Developmental Network (TDN), the clinical research arm of the Cystic Fibrosis Foundation, and a member of the Steering Committee of the TDN. She conducts many research studies in cystic fibrosis. In addition, she is a sub investigator in the BCM Pulmonary Hypertension Center.

Clinical Interests

Dr. Katz is the medical director of the Adult Cystic Fibrosis Center, a comprehensive, multidisciplinary center for the care of adults with cystic fibrosis. Her other clinical interests include asthma, bronchiectasis, interstitial lung disease and COPD.

Awards and Honors

  • The Brown Foundation Endowed Professorship in Adult Cystic Fibrosis, 2008 to present
  • Best Doctors in America® 2009-2010 – Houston Metro Area

Selected Publications

  • Safdar Z, Katz MF, Frost AE. Computed axial tomography evidence of left atrial enlargement: a predictor of elevated pulmonary capillary wedge pressure in pulmonary hypertension. International Journal of General Medicine. 2009; 2010(3):23–9.
  • Oermann CM, Wheeler C, Cumming S, Katz MF. A pilot study evaluating the potential use of low-dose methotrexate as an anti-inflammatory therapy for CF lung disease. Pediatric Pulmonology. 2007; 42(S30):292-3.
  • Kaza V, Katz MF, Cumming S, Frost AE, Safdar Z. Correlation of chest radiograph pattern with genotype, age, and gender in adult cystic fibrosis: a single-center study. Chest. 2007;132(2):569-74.
  • Katz MF, PI of the National Emphysema Treatment Trials, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. NEJM. 2003; 348(21):2059-73.
  • Katz MF, Beer DJ, Duquette DM, Cruickshank WW, Antonov AS, Romano YA,Smirnov VN, Farver HW. Secretion of a novel T-lymphocyte cytokine possessing both chemotactic and growth factor activity by serotonin-stimulated human aortic endothelial cells. Exp Cell Res. 1994; 212(1):113-9.
  • Katz MF, Farber HW, Dodds-Stitt Z, Cruikshank WW, Beer DJ. Serotonin-stimulated aortic endothelial cells secrete a novel T-lymphocyte chemotactic and growth factor. J Leuk Biol. 1994; 55(5):567-73.
  • Katz MF and Beer DJ. T-lymphocyte and cytokine networks in asthma: clinical and therapeutic implications. Adv Intern Med. 1993; 38:189-222.
  • Katz MF, Farber HW, Fox GS, Antonov AS, Beer DJ. Serotonin induction of a novel T-cell activating factor from human aortic endothelial cells. Am Rev Respir Dis. 1991; 1-13:A238.
  • Katz MF, Duquette DM, Farber HW, Cruikshank WW, Beer DJ. Elaboration of a novel T-lymphocyte mitoattractant by aortic endothelial cells. Am Rev Respir Dis. 1990; 141:A914.

E-mail this page to a friend